|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.16 CAD | +3.23% |
|
0.00% | +60.00% |
| Apr. 18 | Entheon Biomedical Corp. announced that it has received CAD 0.1475 million in funding | CI |
| Apr. 11 | Entheon Biomedical Corp. announced that it expects to receive CAD 0.1475 million in funding | CI |
Entheon Biomedical Corp. reported earnings results for the full year ended November 30, 2023. For the full year, the company reported revenue was CAD 0.250323 million compared to CAD 0.189677 million a year ago.
Net loss was CAD 0.300001 million compared to CAD 8.52 million a year ago. Basic loss per share from continuing operations was CAD 0.05 compared to CAD 0.35 a year ago. Basic loss per share was CAD 0.05 compared to CAD 1.44 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +60.00% | 1.04M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
ENTHEON BIOMEDICAL CORP. 
